Office of the United States Trade Representative

Summary

Office of the United States Trade Representative Special 301 Report (2010)

As affirmed in the Doha Declaration on TRIPS and Public Health, the United States respects a country's right to protect public health and, in particular, to promote access to medicines for all, and supports the vital role of the patent system in promoting the development and creation of new and innovative lifesaving medicines.
Source: Wikisource

Office of the United States Trade Representative Special 301 Report (2013)

In particular, India's decision in this case to restrict patent rights of an innovator based, in part, on the innovator's decision to import its products, rather than manufacture them in India, establishes a troubling precedent. Unless overturned, the decision could potentially compel innovators outside India – including those in sectors well beyond pharmaceuticals, such as green technology and information and communications technology – to manufacture in India in order to avoid being forced to license an invention to third parties.
Source: Wikisource

Office of the United States Trade Representative Special 301 Report (2015)

Indeed, trade secrets, such as business plans, internal market analysis, manufacturing methods, and recipes, are often among a company's core business assets; and a company's competitiveness may depend on its capacity to protect such assets.
If a company's trade secrets are stolen by a competitor or the agent of a competitor, it may be extremely difficult, if not impossible, to recoup past investments in R&D, and future innovation may be compromised. Moreover, trade secret theft threatens to diminish U.S. competitiveness around the globe, and puts American jobs at risk.
Source: Wikisource

Get perspective with Kwize: daily news enlightened by great literature